These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 29641418)
1. [Fragile X syndrome and FMR1-dependent diseases - diagnostic scheme based on own experience .]. Landowska A; Rzońca S; Bal J; Gos M Dev Period Med; 2018; 22(1):22-32. PubMed ID: 29641418 [TBL] [Abstract][Full Text] [Related]
2. EMQN best practice guidelines for the molecular genetic testing and reporting of fragile X syndrome and other fragile X-associated disorders. Biancalana V; Glaeser D; McQuaid S; Steinbach P Eur J Hum Genet; 2015 Apr; 23(4):417-25. PubMed ID: 25227148 [TBL] [Abstract][Full Text] [Related]
3. [Triplet expansion cytosine-guanine-guanine: Three cases of OMIM syndrome in the same family]. González-Pérez J; Izquierdo-Álvarez S; Fuertes-Rodrigo C; Monge-Galindo L; Peña-Segura JL; López-Pisón FJ Med Clin (Barc); 2016 Apr; 146(7):311-5. PubMed ID: 26776484 [TBL] [Abstract][Full Text] [Related]
4. Unstable mutations in the FMR1 gene and the phenotypes. Loesch D; Hagerman R Adv Exp Med Biol; 2012; 769():78-114. PubMed ID: 23560306 [TBL] [Abstract][Full Text] [Related]
5. [Fragile X syndrome and FMR1-dependent diseases - clinical presentation, epidemiology and molecular background]. Landowska A; Rzońca S; Bal J; Gos M Dev Period Med; 2018; 22(1):14-21. PubMed ID: 29641417 [TBL] [Abstract][Full Text] [Related]
7. FMR1 premutation carrier frequency in patients undergoing routine population-based carrier screening: insights into the prevalence of fragile X syndrome, fragile X-associated tremor/ataxia syndrome, and fragile X-associated primary ovarian insufficiency in the United States. Hantash FM; Goos DM; Crossley B; Anderson B; Zhang K; Sun W; Strom CM Genet Med; 2011 Jan; 13(1):39-45. PubMed ID: 21116185 [TBL] [Abstract][Full Text] [Related]
8. Newborn, carrier, and early childhood screening recommendations for fragile X. Abrams L; Cronister A; Brown WT; Tassone F; Sherman SL; Finucane B; McConkie-Rosell A; Hagerman R; Kaufmann WE; Picker J; Coffey S; Skinner D; Johnson V; Miller R; Berry-Kravis E Pediatrics; 2012 Dec; 130(6):1126-35. PubMed ID: 23129072 [TBL] [Abstract][Full Text] [Related]
9. Partially methylated alleles, microdeletion, and tissue mosaicism in a fragile X male with tremor and ataxia at 30 years of age: A case report. Hwang YT; Aliaga SM; Arpone M; Francis D; Li X; Chong B; Slater HR; Rogers C; Bretherton L; Hunter M; Heard R; Godler DE Am J Med Genet A; 2016 Dec; 170(12):3327-3332. PubMed ID: 27696642 [TBL] [Abstract][Full Text] [Related]
10. Detecting AGG Interruptions in Male and Female FMR1 Premutation Carriers by Single-Molecule Sequencing. Ardui S; Race V; Zablotskaya A; Hestand MS; Van Esch H; Devriendt K; Matthijs G; Vermeesch JR Hum Mutat; 2017 Mar; 38(3):324-331. PubMed ID: 27883256 [TBL] [Abstract][Full Text] [Related]
11. [Clinical guideline of gene FMR1-associated diseases: fragile X syndrome, primary ovarian insufficiency and tremor-ataxia syndrome]. Milá M; Ramos F; Tejada MI; Med Clin (Barc); 2014 Mar; 142(5):219-25. PubMed ID: 23891128 [No Abstract] [Full Text] [Related]
13. Mechanisms of Genome Instability in the Fragile X-Related Disorders. Hayward BE; Usdin K Genes (Basel); 2021 Oct; 12(10):. PubMed ID: 34681027 [TBL] [Abstract][Full Text] [Related]
14. Fragile X syndrome full mutation in cognitively normal male identified as part of an Australian reproductive carrier screening program. Jarmolowicz AI; Baker EK; Bartlett E; Francis D; Ling L; Gamage D; Delatycki MB; Godler DE Am J Med Genet A; 2021 May; 185(5):1498-1503. PubMed ID: 33544979 [TBL] [Abstract][Full Text] [Related]
15. Clinical, molecular, and pharmacological aspects of FMR1 related disorders. Pugin A; Faundes V; Santa María L; Curotto B; Aliaga S; Salas I; Soto P; Bravo P; Peña MI; Alliende MA Neurologia; 2017 May; 32(4):241-252. PubMed ID: 25529181 [TBL] [Abstract][Full Text] [Related]
16. A genetic study of the FMR1 gene in a Sardinian multiple sclerosis population. Lorefice L; Tranquilli S; Fenu G; Murru MR; Frau J; Rolesu M; Coghe GC; Marrosu F; Marrosu MG; Cocco E Neurol Sci; 2015 Dec; 36(12):2213-20. PubMed ID: 26194536 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of molecular approach in screening for fragile X premutation cases. Refeat MM; El Saied MM; Abdel Raouf ER Ir J Med Sci; 2023 Oct; 192(5):2265-2272. PubMed ID: 36409419 [TBL] [Abstract][Full Text] [Related]
18. [Heterogeneity of clinical characteristics of FMR1-related disorders]. Pereverzeva DS; Tyushkevich SA; Gorbachevskaya NL; Mamokhina UA; Danilina KK Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(7):103-111. PubMed ID: 31464297 [TBL] [Abstract][Full Text] [Related]